Les Masterson is a deputy editor and insurance analyst at Forbes Advisor. He has been a journalist, reporter, editor and content creator for more than 25 years. He has covered insurance for a decade, ...

Prescription drug costs are skyrocketing. Will Medicare Part D bring relief? The law of supply and demand dictates that when competition is scarce, prices will inevitably skyrocket. In the health care ...

Medicare open enrollment, which lasts until Dec. 7, provides beneficiaries the opportunity to evaluate their health care spending, including prescription costs, for 2026. Certain changes, including a ...

Medicare has negotiated list price reductions of up to 85% for 15 widely used drugs in the program, including Novo Nordisk's blockbuster GLP-1 drug Ozempic, officials announced Tuesday. Why it matters ...

The Centers for Medicare and Medicaid Services on Tuesday announced lower prices on 15 costly prescription drugs under Medicare, including Ozempic and Wegovy. The price cuts come through the Medicare ...

Reduced prices for the inaugural round of 10 drugs negotiated by the Biden administration last year will go into effect in January. The latest negotiated prices apply to some of the prescription ...